American Association for Cancer Research
Browse

Supplementary Table 3 from Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma

Download (48.89 kB)
journal contribution
posted on 2023-03-31, 17:08 authored by Katja Harbst, Johan Staaf, Martin Lauss, Anna Karlsson, Anna Måsbäck, Iva Johansson, Pär-Ola Bendahl, Johan Vallon-Christersson, Therese Törngren, Henrik Ekedahl, Jürgen Geisler, Mattias Höglund, Markus Ringnér, Lotta Lundgren, Karin Jirström, Håkan Olsson, Christian Ingvar, Åke Borg, Hensin Tsao, Göran Jönsson

PDF file - 48K, Multi�class SAM analysis revealed 503 probes which were found to significantly differ between the four subtypes in GSE22155 at FDR=0

History

ARTICLE ABSTRACT

Purpose: For primary melanomas, tumor thickness, mitotic rate, and ulceration are well-laid cornerstones of prognostication. However, a molecular exposition of melanoma aggressiveness is critically missing. We recently uncovered a four-class structure in metastatic melanoma, which predicts outcome and informs biology. This raises the possibility that a molecular structure exists even in the early stages of melanoma and that molecular determinants could underlie histophenotype and eventual patient outcome.Experimental Design: We subjected 223 archival primary melanomas to a horizontally integrated analysis of RNA expression, oncogenic mutations at 238 lesions, histomorphometry, and survival data.Results: Our previously described four-class structure that was elucidated in metastatic lesions was evident within the expression space of primary melanomas. Because these subclasses converged into two larger prognostic and phenotypic groups, we used the metastatic lesions to develop a binary subtype-based signature capable of distinguishing between “high” and “low” grade forms of the disease. The two-grade signature was subsequently applied to the primary melanomas. Compared with low-grade tumors, high-grade primary melanomas were significantly associated with increased tumor thickness, mitotic rate, ulceration (all P < 0.01), and poorer relapse-free (HR = 4.94; 95% CI, 2.84–8.59), and overall (HR = 3.66; 95% CI, 2.40–5.58) survival. High-grade melanomas exhibited elevated levels of proliferation and BRCA1/DNA damage signaling genes, whereas low-grade lesions harbored higher expression of immune genes. Importantly, the molecular-grade signature was validated in two external gene expression data sets.Conclusions: We provide evidence for a molecular organization within melanomas, which is preserved across all stages of disease. Clin Cancer Res; 18(15); 4026–36. ©2012 AACR.

Usage metrics

    Clinical Cancer Research

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC